1. Home
  2. ITOS vs BYON Comparison

ITOS vs BYON Comparison

Compare ITOS & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BYON
  • Stock Information
  • Founded
  • ITOS 2011
  • BYON 1997
  • Country
  • ITOS United States
  • BYON United States
  • Employees
  • ITOS N/A
  • BYON N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BYON Catalog/Specialty Distribution
  • Sector
  • ITOS Health Care
  • BYON Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • BYON Nasdaq
  • Market Cap
  • ITOS 381.2M
  • BYON 354.2M
  • IPO Year
  • ITOS 2020
  • BYON N/A
  • Fundamental
  • Price
  • ITOS $10.26
  • BYON $7.90
  • Analyst Decision
  • ITOS Hold
  • BYON Hold
  • Analyst Count
  • ITOS 6
  • BYON 8
  • Target Price
  • ITOS $10.60
  • BYON $10.67
  • AVG Volume (30 Days)
  • ITOS 793.1K
  • BYON 2.5M
  • Earning Date
  • ITOS 08-07-2025
  • BYON 07-28-2025
  • Dividend Yield
  • ITOS N/A
  • BYON N/A
  • EPS Growth
  • ITOS N/A
  • BYON N/A
  • EPS
  • ITOS N/A
  • BYON N/A
  • Revenue
  • ITOS $35,000,000.00
  • BYON $1,244,431,000.00
  • Revenue This Year
  • ITOS N/A
  • BYON N/A
  • Revenue Next Year
  • ITOS N/A
  • BYON $12.55
  • P/E Ratio
  • ITOS N/A
  • BYON N/A
  • Revenue Growth
  • ITOS 177.89
  • BYON N/A
  • 52 Week Low
  • ITOS $4.80
  • BYON $3.54
  • 52 Week High
  • ITOS $18.13
  • BYON $15.44
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 66.97
  • BYON 63.59
  • Support Level
  • ITOS $10.05
  • BYON $7.34
  • Resistance Level
  • ITOS $10.21
  • BYON $8.34
  • Average True Range (ATR)
  • ITOS 0.13
  • BYON 0.58
  • MACD
  • ITOS -0.06
  • BYON 0.09
  • Stochastic Oscillator
  • ITOS 81.48
  • BYON 83.95

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: